Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-063278
Filing Date
2025-07-11
Accepted
2025-07-11 16:15:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 7592
  Complete submission text file 0001213900-25-063278.txt   9424
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Subject) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92718 | Film No.: 251119160
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell (BVI) Ltd (Filed by) CIK: 0001874958 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8
Type: SCHEDULE 13D/A